Revolution Medicines (RVMD) Change in Account Payables (2019 - 2026)

Revolution Medicines has reported Change in Account Payables for 8 years, with the latest figure at $5.0 million in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 42.58% year-over-year to $5.0 million in Q2 2026; TTM through Jun 2026 was $30.9 million, a 14.28% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 247.49% from the prior year.
• Change in Account Payables was $5.0 million for Q2 2026 at Revolution Medicines, down from $16.9 million in the prior quarter.
• The five-year high for Change in Account Payables was $29.4 million in Q4 2024, with the low at -$29.0 million in Q1 2024.
• Average Change in Account Payables over 5 years is $3.6 million, with a median of $44000.0 recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables surged 5317.46% in 2022, then tumbled 2658.1% in 2024.
• Over 5 years, Change in Account Payables stood at -$1.5 million in 2022, then jumped by 1712.81% to $24.3 million in 2023, then increased by 20.81% to $29.4 million in 2024, then slumped by 135.76% to -$10.5 million in 2025, then jumped by 147.91% to $5.0 million in 2026.
• The last three Change in Account Payables figures came in at $5.0 million (Q2 2026), $16.9 million (Q1 2026), and -$10.5 million (Q4 2025), per Business Quant data.